# General Catalyst's Biotech Investments: 26 Startups in Its Portfolio (2026) > The 26 Biotech startups General Catalyst has backed, by stage: $3.2B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/general-catalyst-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Stage not reported 9 - [Dren Bio](https://millionrounds.com/company/dren-bio) - [ArriVent](https://millionrounds.com/company/arrivent) - [Rakuten Medical](https://millionrounds.com/company/rakuten-medical) - [Zageno](https://millionrounds.com/company/zageno) - [Fractyl Health](https://millionrounds.com/company/fractyl-health) - [Ossium Health](https://millionrounds.com/company/ossium-health) - [Mirvie](https://millionrounds.com/company/mirvie) - [*C* Curai](https://millionrounds.com/company/curai) - [CTRL Therapeutics](https://millionrounds.com/company/ctrl-therapeutics) ## Series C and later 8 - [PathAI](https://millionrounds.com/company/pathai) - [Eikon Therapeutics](https://millionrounds.com/company/eikon-therapeutics) - [Odyssey Therapeutics](https://millionrounds.com/company/odyssey-therapeutics) - [Dewpoint Therapeutics](https://millionrounds.com/company/dewpoint-therapeutics) - [Alpha-9 Oncology](https://millionrounds.com/company/alpha-9-oncology) - [*O* OM1](https://millionrounds.com/company/om1) - [Truvian Sciences](https://millionrounds.com/company/truvian-sciences) - [*F* Fractyl](https://millionrounds.com/company/fractyl) ## Series A 5 - [Roman](https://millionrounds.com/company/roman) - [*CG* Color Genomics](https://millionrounds.com/company/color-genomics) - [Enable Medicine](https://millionrounds.com/company/enable-medicine) - [Waypoint Bio](https://millionrounds.com/company/waypoint-bio) - [drchrono](https://millionrounds.com/company/drchrono) ## Series B 4 - [Variant Bio](https://millionrounds.com/company/variant-bio) - [Vial](https://millionrounds.com/company/vial) - [Evvy](https://millionrounds.com/company/evvy) - [Elysium Health](https://millionrounds.com/company/elysium-health) ## Segment by segment ### Stage not reported 9 startups · $1.0B raised - [**Dren Bio**](https://millionrounds.com/company/dren-bio) Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents. United States $375M - [**ArriVent**](https://millionrounds.com/company/arrivent) ArriVent develops pharmaceutical products to cure presently untreatable cancer. United States $325M - [**Rakuten Medical**](https://millionrounds.com/company/rakuten-medical) Rakuten Medical, Inc. United States $109M - [**Zageno**](https://millionrounds.com/company/zageno) ZAGENO is an enterprise marketplace solution that connects e-commerce to life science. United States $61M - [**Fractyl Health**](https://millionrounds.com/company/fractyl-health) Fractyl Health is a biotechnology company that provides curative therapies for metabolic diseases. United States $60M - [**Ossium Health**](https://millionrounds.com/company/ossium-health) Ossium Health is a bioengineering and therapeutics company based in San Francisco, California, founded in 2016. United States $52M - [**Mirvie**](https://millionrounds.com/company/mirvie) Mirvie is a biotechnology company based in South San Francisco, California, focused on improving pregnancy health through early de United States $24M - [*C* **Curai**](https://millionrounds.com/company/curai) United States $11M ### Series C and later 8 startups · $1.7B raised - [**PathAI**](https://millionrounds.com/company/pathai) PathAI develops technology that assists pathologists in making accurate diagnoses for every patient, every time. United States $400M - [**Eikon Therapeutics**](https://millionrounds.com/company/eikon-therapeutics) Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery. United States $351M - [**Odyssey Therapeutics**](https://millionrounds.com/company/odyssey-therapeutics) Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases. United States $238M - [**Dewpoint Therapeutics**](https://millionrounds.com/company/dewpoint-therapeutics) Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates. United States $196M - [**Alpha-9 Oncology**](https://millionrounds.com/company/alpha-9-oncology) Alpha-9 Oncology is a clinical-stage radiopharmaceutical company focused on developing targeted treatments for cancer. Canada $175M - [*O* **OM1**](https://millionrounds.com/company/om1) United States $171M - [**Truvian Sciences**](https://millionrounds.com/company/truvian-sciences) Truvian Sciences develops an automated benchtop system to provide lab-accurate blood testing results. United States $101M - [*F* **Fractyl**](https://millionrounds.com/company/fractyl) United States $44M ### Series A 5 startups · $271M raised - [**Roman**](https://millionrounds.com/company/roman) Roman is a manufacturer and distributor of Christmas items and gift products. United States $88M - [*CG* **Color Genomics**](https://millionrounds.com/company/color-genomics) United States $60M - [**Enable Medicine**](https://millionrounds.com/company/enable-medicine) Enable medicine is a biotechnology company that develops biological cartography tools to generate cellular maps that help in drug discovery. United States $60M - [**Waypoint Bio**](https://millionrounds.com/company/waypoint-bio) Waypoint Bio is a biotechnology startup based in New York City, founded in 2021. United States $35M - [**drchrono**](https://millionrounds.com/company/drchrono) The essential platform for modern medical practices to make care more informed, more interactive, and more personalized. United States $28M ### Series B 4 startups · $251M raised - [**Variant Bio**](https://millionrounds.com/company/variant-bio) Variant Bio is a biotechnology company based in Seattle, founded in 2018. United States $105M - [**Vial**](https://millionrounds.com/company/vial) Scalable biotech advancing clinical programs with cost-effective trials and computationally designed therapeutics. United States $67M - [**Evvy**](https://millionrounds.com/company/evvy) Evvy is a women's health technology company based in New York, focused on addressing the gender health gap through precision medicine. United States $54M - [**Elysium Health**](https://millionrounds.com/company/elysium-health) Elysium Health is a New York-based manufacturer of dietary supplements and consumer health products, focused on translating scient United States $25M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names General Catalyst as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **General Catalyst's AI portfolio** 226 startups · $179B](https://millionrounds.com/portfolio-maps/general-catalyst-ai-portfolio)[Sector portfolio **General Catalyst's Healthtech portfolio** 55 startups · $9.3B](https://millionrounds.com/portfolio-maps/general-catalyst-healthtech-portfolio)[Sector portfolio **General Catalyst's Fintech portfolio** 53 startups · $16B](https://millionrounds.com/portfolio-maps/general-catalyst-fintech-portfolio)[Sector portfolio **General Catalyst's IT Services portfolio** 31 startups · $1.8B](https://millionrounds.com/portfolio-maps/general-catalyst-it-services-portfolio)[Sector portfolio **General Catalyst's Web3 & Crypto portfolio** 26 startups · $4.1B](https://millionrounds.com/portfolio-maps/general-catalyst-web3-crypto-portfolio)[Sector portfolio **General Catalyst's Internet portfolio** 22 startups · $8.5B](https://millionrounds.com/portfolio-maps/general-catalyst-internet-portfolio) ## Raising from investors like General Catalyst? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)